References
- Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK. Septic reactions to platelet transfusions: a persistent problem. Jama 1991;266(4): 555–558. doi:https://doi.org/10.1001/jama.1991.03470040119033
- Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7(3): 290–302. doi:https://doi.org/10.1128/CMR.7.3.290
- Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44(1): 10–15. doi:https://doi.org/10.1046/j.0041-1132.2003.00518.x
- Lin JS, Tzeng CH, Hao TC, Hu HY, Ho YT, Lyou JY, Liu J, Ho CH, Yung CH. Cytokine release in febrile non‐haemolytic red cell transfusion reactions. Vox Sang 2002;82(3): 156–160. doi:https://doi.org/10.1046/j.1423-0410.2002.00159.x
- King KE, Shirey RS, Thoman SK, Bensen‐Kennedy D, Tanz WS, Ness PM. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004;44(1): 25–29. doi:https://doi.org/10.1046/j.0041-1132.2004.00609.x
- Pruss A, Kalus U, Radtke H, Koscielny J, Baumann-Baretti B, Balzer D, Dörner T, Salama A, Kiesewetter H. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apher Sci 2004;30(1): 41–46. doi:https://doi.org/10.1016/j.transci.2003.08.013
- Taylor C, Navarrete C, Contreras M. Immunological complications of blood transfusion. Transfus Altern Transfus Med 2008;10(3): 112–126. doi:https://doi.org/10.1111/j.1778-428X.2008.00116.x
- Chang CC, Lee TC, Su MJ, Lin HC, Cheng FY, Chen YT, Yen TH, Chu FY. Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction. Oncotarget 2018;9(4): 4385. doi:https://doi.org/10.18632/oncotarget.23136
- Blajchman. Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang 1998;74(S2):155–159. doi:https://doi.org/10.1111/j.1423-0410.1998.tb05414.x
- Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine—blood transfusion. N Engl J Med 1999;340(6): 438–447. doi:https://doi.org/10.1056/NEJM199902113400606
- Ali H, Greco-Stewart VS, Jacobs MR, Yomtovian RA, Rood IG, de Korte D, Ramírez-Arcos SM. Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units. Int J Med Microbiol 2014;63(6): 884–891. doi:https://doi.org/10.1099/jmm.0.071449-0
- Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009;113(15): 3406–3417. doi:https://doi.org/10.1182/blood-2008-10-167643
- Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115(6): 457–469. doi:https://doi.org/10.7326/0003-4819-115-6-457
- Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007;335(7625): 879–883. doi:https://doi.org/10.1136/bmj.39346.495880.AE
- Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6(11): 813. doi:https://doi.org/10.1038/nri1943
- Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015;35(12): 2562–2570. doi:https://doi.org/10.1161/ATVBAHA.115.306528
- Gawaz M, Fateh‐Moghadam S, Pilz G, GURLAND HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995;25(11): 843–851. doi:https://doi.org/10.1111/j.1365-2362.1995.tb01694.x
- Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 2018;44(6): 925–928. doi:https://doi.org/10.1007/s00134-018-5085-0
- Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. ASH Education Program Book 2003;2003(1):575–589
- Na S, Af A, Wf A. Detection of endotoxins and bacterial agents in collected blood bags and their recipients. J High Inst Public Health 2009;39(2): 305–321. doi:https://doi.org/10.21608/jhiph.2009.20757
- Arduino MJ, Bland LA, Tipple MA, Aguero SM, Favero MS, Jarvis WR. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 1989;27(7): 1483–1485. doi:https://doi.org/10.1128/JCM.27.7.1483-1485.1989
- Morrison DC, Ryan JL Bacterial endotoxins and host immune responses. Adv Immunol. Volume 28: Elsevier; 1980. p 293–450.
- Eng RHK, Smith SM, Fan-Havard P, Ogbara T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis 1993;16(3): 185–189. doi:https://doi.org/10.1016/0732-8893(93)90109-K
- Morrison DC, Bucklin SE, Leeson MC, Norimatsu M. Contribution of soluble endotoxin released from Gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice. J of Endotoxin Res 1996;3(3): 237–243. doi:https://doi.org/10.1177/096805199600300309
- Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18(1): 195–204. doi:https://doi.org/10.1128/CMR.18.1.195-204.2005
- Schrezenmeier H, Walther‐Wenke G, Müller TH, Weinauer F, Younis A, Holland‐Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood–derived platelets and apheresis platelets. Transfusion 2007;47(4): 644–652. doi:https://doi.org/10.1111/j.1537-2995.2007.01166.x
- Dumont LJ, Kleinman S, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P. BLOOD COMPONENTS: screening of single‐donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50(3): 589–599. doi:https://doi.org/10.1111/j.1537-2995.2009.02460.x
- Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion 2000;40(11): 1308–1312. doi:https://doi.org/10.1046/j.1537-2995.2000.40111308.x
- Védy D, Robert D, Gasparini D, Canellini G, Waldvogel S, Tissot J-D. Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods. Hematol Rev 2009;1:1
- Ramírez‐Arcos S, Chin‐Yee I, Hume H, Fearon M, Goldman M, Eckert K, Martincic I, Peters G, Kovach D, Richardson SE. Fatal septic shock associated with transfusion‐transmitted Serratia marcescens. Transfusion 2006;46(4): 679–681. doi:https://doi.org/10.1111/j.1537-2995.2006.00783.x
- Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15(2): 167–193. doi:https://doi.org/10.1128/CMR.15.2.167-193.2002
- Costerton JW, Cheng K, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987;41(1): 435–464. doi:https://doi.org/10.1146/annurev.mi.41.100187.002251
- Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322:85–105. doi:https://doi.org/10.1007/978-3-540-75418-3_5.
- Desrousseaux C, Sautou V, Descamps S, Traoré O. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation. J Hosp Infect 2013;85(2): 87–93. doi:https://doi.org/10.1016/j.jhin.2013.06.015
- Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol 2001;55(1): 165–199. doi:https://doi.org/10.1146/annurev.micro.55.1.165
- Greco C, Martincic I, Gusinjac A, Kalab M, Yang AF, Ramírez‐Arcos S. Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions. Transfusion 2007;47(7): 1143–1153. doi:https://doi.org/10.1111/j.1537-2995.2007.01249.x
- Greco C, Mastronardi C, Pagotto F, Mack D, Ramirez‐Arcos S. Assessment of biofilm‐forming ability of coagulase‐negative staphylococci isolated from contaminated platelet preparations in Canada. Transfusion 2008;48(5): 969–977. doi:https://doi.org/10.1111/j.1537-2995.2007.01631.x
- Greco-Stewart VS, Ali H, Kumaran D, Kalab M, Rood IG, de Korte D, Ramírez-Arcos S. Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates. J Med Microbiol 2013;62(7): 1051–1059. doi:https://doi.org/10.1099/jmm.0.050500-0
- Dice B, Stoodley P, Buchinsky F, Metha N, Ehrlich GD, Hu FZ. Biofilm formation by ica-positive and ica-negative strains of Staphylococcus epidermidis in vitro. Biofouling 2009;25(4): 367–375. doi:https://doi.org/10.1080/08927010902803297
- Greco‐Stewart V, Brown E, Parr C, Kalab M, Jacobs M, Yomtovian R, Ramírez‐Arcos S. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang 2012;102(3): 212–220. doi:https://doi.org/10.1111/j.1423-0410.2011.01550.x
- Loza-Correa M, Ayala JA, Perelman I, Hubbard K, Kalab M, Yi Q-L, Taha M, de Pedro MA, Ramirez-Arcos S. The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets. PloS One 2019;14(1): e0211132. doi:https://doi.org/10.1371/journal.pone.0211132
- Alabdullatif M, Atreya CD, Ramirez‐Arcos S. Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates. Transfusion 2018;58(8): 2013–2021. doi:https://doi.org/10.1111/trf.14646
- Wilson-Nieuwenhuis JS, Dempsey-Hibbert N, Liauw CM, Whitehead KA. Surface modification of platelet concentrate bags to reduce biofilm formation and transfusion sepsis. Colloids Surf B 2017;160: 126–135. doi:https://doi.org/10.1016/j.colsurfb.2017.09.019
- Hadjesfandiari N, Weinhart M, Kizhakkedathu JN, Haag R, Brooks DE. Development of antifouling and bactericidal coatings for platelet storage bags using dopamine chemistry. Adv Healthc Mater 2018;7(5): 1700839. doi:https://doi.org/10.1002/adhm.201700839
- Services USDoHH. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Food and Drug Administration, Center for Biologics Evaluation and Research. 2019.
- Thorpe TC, Wilson M, Turner J, DiGuiseppi J, Willert M, Mirrett S, Reller L. BacT/alert: an automated colorimetric microbial detection system. J Clin Microbiol 1990;28(7): 1608–1612. doi:https://doi.org/10.1128/JCM.28.7.1608-1612.1990
- Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two‐bottle culture systems and an estimation of false‐negative culture rates. Transfusion 2007;47(8): 1381–1389. doi:https://doi.org/10.1111/j.1537-2995.2007.01326.x
- Totty H, Ullery M, Spontak J, Viray J, Adamik M, Katzin B, Dunne W, Deol P. A controlled comparison of the BacT/ALERT® 3D and VIRTUO™ microbial detection systems. Eur J Clin Microbiol Infect Dis 2017;36(10): 1795–1800. doi:https://doi.org/10.1007/s10096-017-2994-8
- Nussbaumer W, Allersdorfer D, Grabmer C, Rheinschmidt M, Lin L, Schönitzer D, Lass‐Flörl C. Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Transfusion 2007;47(7): 1125–1133. doi:https://doi.org/10.1111/j.1537-2995.2007.01247.x
- Burillo A, Bouza E. Use of rapid diagnostic techniques in ICU patients with infections. BMC Infect Dis 2014;14(1): 593. doi:https://doi.org/10.1186/s12879-014-0593-1
- Watanabe N, Kryukov K, Nakagawa S, Takeuchi JS, Takeshita M, Kirimura Y, Mitsuhashi S, Ishihara T, Aoki H, Inokuchi S. Detection of pathogenic bacteria in the blood from sepsis patients using 16S rRNA gene amplicon sequencing analysis. PloS One 2018;13(8): e0202049. doi:https://doi.org/10.1371/journal.pone.0202049
- Casalta J, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. Evaluation of the LightCycler® SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009;28(6): 569–573. doi:https://doi.org/10.1007/s10096-008-0672-6
- Dierkes C, Ehrenstein B, Siebig S, Linde H-J, Reischl U, Salzberger B. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9(1): 126. doi:https://doi.org/10.1186/1471-2334-9-126
- Gosiewski FA, Sroka A, Kędzierska A, Pietrzyk A, Kędzierska J, Drwiła R, Bulanda M. Comparison of nested, multiplex, qPCR; FISH; SeptiFast and blood culture methods in detection and identification of bacteria and fungi in blood of patients with sepsis. BMC Microbiol 2014;14(1): 313. doi:https://doi.org/10.1186/s12866-014-0313-4
- Korber F, Zeller I, Grünstäudl M, Willinger B, Apfalter P, Hirschl AM, Makristathis A. SeptiFast versus blood culture in clinical routine–A report on 3 years experience. Wien Klin Wochenschr 2017;129(11–12): 427–434. doi:https://doi.org/10.1007/s00508-017-1181-3
- Grif K, Fille M, Würzner R, Weiss G, Lorenz I, Gruber G, Eschertzhuber S, Nachbaur D, Lass-Flörl C, Orth D. Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr 2012;124(7–8): 266–270. doi:https://doi.org/10.1007/s00508-012-0159-4
- Paolucci M, Stanzani M, Melchionda F, Tolomelli G, Castellani G, Landini MP, Varani S, Lewis RE, Sambri V. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 2013;75(2): 130–134. doi:https://doi.org/10.1016/j.diagmicrobio.2012.10.012
- Mencacci A, Leli C, Cardaccia A, Montagna P, Moretti A, Bietolini C, Meucci M, Perito S, Cenci E, Bistoni F. Comparison of conventional culture with SeptiFast real-time PCR for microbial pathogen detection in clinical specimens other than blood. J Med Microbiol 2011;60(12): 1774–1778. doi:https://doi.org/10.1099/jmm.0.034280-0
- Gosiewski T, Ludwig-Galezowska A, Huminska K, Sroka-Oleksiak A, Radkowski P, Salamon D, Wojciechowicz J, Kus-Slowinska M, Bulanda M, Wolkow P. Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method-the observation of DNAemia. Eur J Clin Microbiol Infect Dis 2017;36(2): 329–336. doi:https://doi.org/10.1007/s10096-016-2805-7
- GuoHui B, Chunhui Y, Miao H, Hong W, Jiaxin L, Ye C, Hong Y, Zhong L, Wuping L. Three different bacterial detection systems for platelet concentrates under inter-laboratory conditions. Transfus Apher Sci 2013;49(3): 600–607. doi:https://doi.org/10.1016/j.transci.2013.07.029
- Castillo DJ, Rifkin RF, Cowan DA, Potgieter M. The healthy human blood microbiome: fact or fiction? Front Cell Infect Microbiol 2019;9: 148. doi:https://doi.org/10.3389/fcimb.2019.00148
- Vollmer T, Engemann J, Kleesiek K, Dreier J. Bacterial screening by flow cytometry offers potential for extension of platelet storage: results of 14 months of active surveillance. Transfus Med 2011;21(3): 175–182. doi:https://doi.org/10.1111/j.1365-3148.2011.01070.x
- Vollmer DJ, Schottstedt V, Bux J, Tapernon K, Sibrowski W, Kleesiek K, Knabbe C. Detection of bacterial contamination in platelet concentrates by a sensitive flow cytometric assay (BactiFlow): a multicentre validation study. Transfus Med 2012;22(4): 262–271. doi:https://doi.org/10.1111/j.1365-3148.2012.01166.x
- Vollmer T, Schottstedt V, Bux J, Walther-Wenke G, Knabbe C, Dreier J. Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? Blood Transfus 2014;12(3): 388. doi:https://doi.org/10.2450/2014.0032-14s
- Irsch J, Lin L. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood SystemTM. Transfus Med Hemother 2011;38(1): 19–31. doi:https://doi.org/10.1159/000323937
- Perez‐Pujol S, Tonda R, Lozano M, Fuste B, Lopez‐Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Effects of a new pathogen‐reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfus 2005;45(6): 911–919. doi:https://doi.org/10.1111/j.1537-2995.2005.04350.x
- Sonego G, Abonnenc M, Crettaz D, Lion N, Tissot JD, Prudent M. Irreversible oxidations of platelet proteins after riboflavin-UVB pathogen inactivation. Transfus Clin Biol 2020; 27(1):36-42. doi:https://doi.org/10.1016/j.tracli.2018.12.001.
- Estcourt LJ, Malouf R, Hopewell S, Trivella M, Doree C, Stanworth SJ, Murphy MF. Pathogen‐reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev 2017;7, CD009072.
- Bahar B, Schulz WL, Gokhale A, Spencer BR, Gehrie EA, Snyder EL. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets. Br J Haematol 2020;188(3): 465–472. doi:https://doi.org/10.1111/bjh.16187
- Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, Müller TH, Völker U. BLOOD COMPONENTS: A novel approach to pathogen reduction in platelet concentrates using short‐wave ultraviolet light. Transfus 2009;49(12): 2612–2624. doi:https://doi.org/10.1111/j.1537-2995.2009.02334.x
- Seltsam A, Müller TH. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011;38(1): 43–54. doi:https://doi.org/10.1159/000323845
- Thiele T, Pohler P, Kohlmann T, Sümnig A, Aurich K, Selleng K, Westphal A, Bakchoul T, Petersmann A, Müller TH. Tolerance of platelet concentrates treated with UVC‐light only for pathogen reduction–a phase I clinical trial. Vox Sang 2015;109(1): 44–51. doi:https://doi.org/10.1111/vox.12247
- SaBTO Advisory Committee on the Safety of Blood TaO. Pathogen Inactivation of Platelets. Report of The SaBTO Working Group. 2014.
- Corash L. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis. Expert Rev Hematol 2011;4(5): 509–525. doi:https://doi.org/10.1586/ehm.11.53
- Wain J, Diep TS, Ho VA, Walsh AM, Hoa NTT, Parry CM, White NJ. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998;36(6): 1683–1687. doi:https://doi.org/10.1128/JCM.36.6.1683-1687.1998
- Sabui T, Tudehope D, Tilse M. Clinical significance of quantitative blood cultures in newborn infants. J Paediatr Child Health 1999;35(6): 578–581. doi:https://doi.org/10.1046/j.1440-1754.1999.00429.x
- Shrum B, Anantha RV, Xu SX, Donnelly M, Haeryfar SM, McCormick JK, Mele T. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes 2014;7(1): 233. doi:https://doi.org/10.1186/1756-0500-7-233
- Opota O, Jaton K, Greub G. Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. Clin Microbiol Infect 2015;21(4): 323–331. doi:https://doi.org/10.1016/j.cmi.2015.02.005
- Yomtovian RA, Palavecino EL, Dysktra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion 2006;46(5): 719–730. doi:https://doi.org/10.1111/j.1537-2995.2006.00790.x
- Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46(8): 1214–1220. doi:https://doi.org/10.1086/529143
- Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS. Immunosuppression in patients who die of sepsis and multiple organ failure. Jama 2011;306(23): 2594–2605. doi:https://doi.org/10.1001/jama.2011.1829
- Störmer M, Kleesiek K, Dreier J. Propionibacterium acnes lacks the capability to proliferate in platelet concentrates. Vox Sang 2008;94(3): 193–201. doi:https://doi.org/10.1111/j.1423-0410.2007.01019.x
- Schneider T, Breviere D, Taillefer M, Pujol-Rey A, Huart J. Bacterial contamination of platelet concentrates by Propionibacterium acnes. Transfus Clin Biol 2000;7(6): 540–546. doi:https://doi.org/10.1016/S1246-7820(01)80004-5
- Perry A, Lambert P. Propionibacterium acnes. Lett Appl Microbiol 2006;42(3): 185–188. doi:https://doi.org/10.1111/j.1472-765X.2006.01866.x
- Walther-Wenke G, Schrezenmeier H, Deitenbeck R, Geis G, Burkhart J, Höchsmann B, Sireis W, Schmidt M, Seifried E, Gebauer W. Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up. Ann Hematol 2010;89(1): 83. doi:https://doi.org/10.1007/s00277-009-0762-2
- Gangahar D, Delany H. Intrasplenic abscess: two case reports and review of the literature. Am Surgeon 1981;47(11):488–491
- Moreira AL, Haslett PA, Symmans WF, Tierno PM. Propionibacterium acnes as the cause of endocarditis in a liver transplant recipient. Clin Infect Dis 2000;30(1): 224–226. doi:https://doi.org/10.1086/313627
- Bolton‐Maggs P. SHOT conference report 2016: serious hazards of transfusion–human factors continue to cause most transfusion‐related incidents. Transfus Med 2016;26(6): 401–405. doi:https://doi.org/10.1111/tme.12380
- Bolton‐Maggs P. Serious hazards of transfusion–conference report: celebration of 20 years of UK haemovigilance. Transfus Med 2017;27(6): 393–400. doi:https://doi.org/10.1111/tme.12502
- Bolton‐Maggs P. Conference report: international haemovigilance seminar and the SHOT annual symposium, 10–12 July 2018. Transfus Med 2019;29(4): 247–252. doi:https://doi.org/10.1111/tme.12569
- Cox D, Kerrigan SW, Watson S. Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation. J Thromb Haemost 2011;9(6): 1097–1107. doi:https://doi.org/10.1111/j.1538-7836.2011.04264.x
- O´ Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A. Mol Microbiol 2002;44(4): 1033–1044. doi:https://doi.org/10.1046/j.1365-2958.2002.02935.x
- Kerrigan SW, Jakubovics NS, Keane C, Maguire P, Wynne K, Jenkinson HF, Cox D. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 2007;75(12): 5740–5747. doi:https://doi.org/10.1128/IAI.00909-07
- Petersen HJ, Keane C, Jenkinson HF, Vickerman MM, Jesionowski A, Waterhouse JC, Cox D, Kerrigan SW. Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun 2010;78(1): 413–422. doi:https://doi.org/10.1128/IAI.00664-09
- Haworth JA, Jenkinson HF, Petersen HJ, Back CR, Brittan JL, Kerrigan SW, Nobbs AH. Concerted functions of Streptococcus gordonii surface proteins PadA and Hsa mediate activation of human platelets and interactions with extracellular matrix. Cell Microbiol 2017;19(1): e12667. doi:https://doi.org/10.1111/cmi.12667
- Zhang G, Han J, Welch EJ, Richard DY, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182(12): 7997–8004. doi:https://doi.org/10.4049/jimmunol.0802884
- Waller AK, Sage T, Kumar C, Carr T, Gibbins JM, Clarke SR. Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J Infect Dis 2013;208(12): 2046–2057. doi:https://doi.org/10.1093/infdis/jit398
- Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, Kerrigan SW, Watson SP. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood 2014;123(20): 3166–3174. doi:https://doi.org/10.1182/blood-2013-11-540526
- Watson CN, Kerrigan SW, Cox D, Henderson IR, Watson SP, Arman M. Human platelet activation by Escherichia coli: roles for FcgammaRIIA and integrin alphaIIbbeta3. Platelets 2016;27(6): 535–540. doi:https://doi.org/10.3109/09537104.2016.1148129
- Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, Foster TJ. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005;57(3): 804–818. doi:https://doi.org/10.1111/j.1365-2958.2005.04731.x
- Ilkan Z, Watson S, Watson SP, Mahaut-Smith MP. P2X1 Receptors Amplify FcgammaRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets. Thromb Haemost 2018;118(2): 369–380. doi:https://doi.org/10.1160/TH17-07-0530
- Sjöbring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002;100(13): 4470–4477. doi:https://doi.org/10.1182/blood-2002-01-0069
- Shannon O, Hertzén E, Norrby‐Teglund A, Mörgelin M, Sjöbring U, Björck L. Severe streptococcal infection is associated with M protein‐induced platelet activation and thrombus formation. Mol Microbiol 2007;65(5): 1147–1157. doi:https://doi.org/10.1111/j.1365-2958.2007.05841.x
- Svensson L, Baumgarten M, Mörgelin M, Shannon O. Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape. Infect Immun 2014;82(10): 4307–4314. doi:https://doi.org/10.1128/IAI.02020-14
- Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci 2010;67(4): 513–523. doi:https://doi.org/10.1007/s00018-009-0207-z
- Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006;4(6): 445. doi:https://doi.org/10.1038/nrmicro1425
- Beachey EH, Chiang TM, Ofek I, Kang AH. Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun 1977;16(2): 649–654. doi:https://doi.org/10.1128/IAI.16.2.649-654.1977
- Wilson-Nieuwenhuis JS, Whitehead KA, Dempsey-Hibbert NC. Bacterial contamination of platelet transfusion units affects platelet haemostatic function and immunological activity. EMJ Hematol 2018;6(1):48–49
- Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud C-A, Eyraud M-A, Zéni F, Pozzetto B, McNicol A, Garraud O, Cognasse F. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol 2012;145(3): 189–200. doi:https://doi.org/10.1016/j.clim.2012.09.004
- Ketter PM, Kamucheka R, Arulanandam B, Akers K, Cap AP. Platelet enhancement of bacterial growth during room temperature storage: mitigation through refrigeration. Transfusion 2019;59(S2): 1479–1489. doi:https://doi.org/10.1111/trf.15255
- Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections–complex interactions with bacteria. Front immun 2015;6: 82. doi:https://doi.org/10.3389/fimmu.2015.00082
- Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015;114(9): 449–458. doi:https://doi.org/10.1160/TH14-12-1067
- Cognasse F, Hamzeh‐Cognasse H, Lafarge S, Delezay O, Pozzetto B, McNicol A, Garraud O. Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008;141(1): 84–91. doi:https://doi.org/10.1111/j.1365-2141.2008.06999.x
- Youssefian T, Drouin A, Massé J-M, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002;99(11): 4021–4029. doi:https://doi.org/10.1182/blood-2001-12-0191
- Li X, Iwai T, Nakamura H, Inoue Y, Chen Y, Umeda M, Suzuki H. An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation. Thromb Res 2008;122(6): 810–819. doi:https://doi.org/10.1016/j.thromres.2008.03.011
- Antczak AJ, Vieth JA, Singh N, Worth RG. Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets. Clin Vaccine Immunol 2011;18(2): 210–216. doi:https://doi.org/10.1128/CVI.00296-10
- Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman JE. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 2005;25(11): 2428–2434. doi:https://doi.org/10.1161/01.ATV.0000184765.59207.f3
- McNicol A, Agpalza A, Jackson E, Hamzeh‐Cognasse H, Garraud O, Cognasse F. Streptococcus sanguinis‐induced cytokine release from platelets. J Thromb Haemost 2011;9(10): 2038–2049. doi:https://doi.org/10.1111/j.1538-7836.2011.04462.x
- Stojewska M, Wąsek-Buko M, Jakub B, Wiśniewska-Ulfig D, Goleniowska-Król A, Szymańska A, Godula-Stuglik U Evaluation of serum chemokine RANTES concentration as a biomarker in the diagnosis of early-onset severe infections in neonates. Advances in Hygiene & Experimental Medicine/Postepy Higieny i Medycyny Doswiadczalnej. 2016;70.
- Hwaiz R, Rahman M, Zhang E, Thorlacius H. Platelet secretion of CXCL4 is Rac1‐dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol 2015;172(22): 5347–5359. doi:https://doi.org/10.1111/bph.13325
- Grommes J, Alard J-E, Drechsler M, Wantha S, Mörgelin M, Kuebler WM, Jacobs M, von Hundelshausen P, Markart P, Wygrecka M. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med 2012;185(6): 628–636. doi:https://doi.org/10.1164/rccm.201108-1533OC
- Rahman M, Roller J, Zhang S, Syk I, Menger MD, Jeppsson B, Thorlacius H. Metalloproteinases regulate CD40L shedding from platelets and pulmonary recruitment of neutrophils in abdominal sepsis. Inflamm Res 2012;61(6): 571–579. doi:https://doi.org/10.1007/s00011-012-0446-6
- Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD 40 L is regulated by matrix metalloproteinase‐9 in abdominal sepsis. J Thromb Haemost 2013;11(7): 1385–1398. doi:https://doi.org/10.1111/jth.12273
- Lorente L, Martín MM, Varo N, Borreguero-León JM, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Jiménez A, Pastor E. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 2011;15(2): R97. doi:https://doi.org/10.1186/cc10104
- Lorente L, Martín MM, Pérez-Cejas A, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Jiménez A. Non-survivor septic patients have persistently higher serum sCD40L levels than survivors. J Critical Care 2017;41: 177–182. doi:https://doi.org/10.1016/j.jcrc.2017.05.021
- Tuinman PR, Juffermans NP. Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects? Crit Care 2011;15(3): 429. doi:https://doi.org/10.1186/cc10237
- Kraft R, Herndon DN, Finnerty CC, Cox RA, Song J, Jeschke MG. Predictive value of IL-8 for sepsis and severe infections after burn injury-A clinical study. Shock (Augusta, Ga) 2015;43(3): 222. doi:https://doi.org/10.1097/SHK.0000000000000294
- Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg 2009;33(3): 558–566. doi:https://doi.org/10.1007/s00268-008-9896-y
- Mokart D, Merlin M, Sannini A, Brun J, Delpero J, Houvenaeghel G, Moutardier V, Blache J. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005;94(6): 767–773. doi:https://doi.org/10.1093/bja/aei143
- Haasper C, Kalmbach M, Dikos G, Meller R, Müller C, Krettek C, Hildebrand F, Frink M. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care 2010;18(2): 89–100. doi:https://doi.org/10.3233/THC-2010-0571
- Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C, Armaganidis A, Roussos C, Orfanos SE. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36(5–6): 283–290. doi:https://doi.org/10.1016/j.cyto.2007.02.007
- Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11(2): R49. doi:https://doi.org/10.1186/cc5783
- Lourbakos A, Yuan Y, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN. Activation of protease-activated receptors by gingipains fromPorphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 2001;97(12): 3790–3797. doi:https://doi.org/10.1182/blood.V97.12.3790
- McRedmond JP, Harriott P, Walker B, Fitzgerald DJ. Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1. Blood 2000;95(4): 1301–1308. doi:https://doi.org/10.1182/blood.V95.4.1301.004k24_1301_1308
- Neumann F-J, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schömig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95(10): 2387–2394. doi:https://doi.org/10.1161/01.CIR.95.10.2387
- Cohen R, Escorcia A, Tasmin F, Lima A, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti‐Gazdewich C. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions. Transfusion 2017;57(7): 1674–1683. doi:https://doi.org/10.1111/trf.14099